Overview
Temoside 20mg is a drug that contains Temozolomide, which is an oral chemotherapy drug used mostly for the treatment of specific brain tumors. Temozolomide acts as an alkylating agent that affects the DNA of cancer cells, hindering them from growing or growing.
Temozolomide is most often prescribed to treat glioblastoma multiforme (GBM) and anaplastic astrocytoma, the most aggressive form of brain tumors. It can be administered by itself or as a part of radiation treatment.
Composition
- Brand Name: Temoside
- Active Ingredient: Temozolomide 20mg
- Dosage Form: Oral capsules or tablets
- Manufacturer: (varies by pharmaceutical company)
Mechanism of Action
Temozolomide is a prodrug that converts to its active metabolite, MTIC (5-(3-methyltriazen-1-yl)-imidazole-4-carboxamide), in the bloodstream. MTIC alters DNA, specifically at the O6 or N7 position of guanine, creating DNA damage, which induces the death of cancerous cells. The specialized toxicity of growing tumor cells makes Temozolomide beneficial in treating brain cancer.
Indications / Uses
Temoside 20mg (Temozolomide) is indicated for:
- Glioblastoma Multiforme (GBM):
- The first line of treatment following surgery and radiation therapy.
- Treatment for maintenance to slow the growth of tumors.
- Anaplastic Astrocytoma:
- In combination with radiation.
- Other Brain Tumors (off-label use):
- Treatment of brain tumors and malignant gliomas susceptible to alkylating agents.
Dosage and Administration
- Adult Dosage:
- A typical dose for starting is 75mg/m² to 150-200mg/m² every day, depending on the treatment phase.
- Most often, it is administered for five consecutive days over 28 days.
- Dose adjustment based upon patient tolerance, blood counts, and the treatment response.
- Administration:
- Orally taken, preferring to do so in a stomach empty (1 an hour before or 2 hours after a meal).
- Take capsules with water and swallow them.
- Dosage should be customized with an Oncologist.
Benefits of Temoside 20mg
- An effective oral chemotherapy method for brain tumors with a high risk of spreading.
- It can cross the blood-brain barrier directly to treat brain tumors.
- Utilized in conjunction with radiation to increase the rate of survival.
- It is often more easily tolerated than certain intravenous chemotherapies.
- Allows outpatient treatment, improving patient convenience.
Side Effects
Temozolomide can cause a variety of adverse reactions, including some that are common but others that are graver.
Common Side Effects:
- Nausea and vomiting
- Fatigue
- Loss of appetite
- Constipation or diarrhea
- Headache
- Hair thinning or hair loss
Serious Side Effects:
- Bone marrow suppression leading to:
- Low white blood cells (risk of infection)
- Low platelets (risk of bleeding)
- Anemia
- Liver toxicity (rare)
- Allergic reactions (rash, swelling)
- Seizures (due to underlying disease or drug)
- Secondary malignancies (rare but possible with long-term use)
Contraindications
- Hypersensitivity to Temozolomide or dacarbazine.
- Bone marrow suppression severe.
- Pregnancy and breastfeeding (due to potential harm to fetus or infant).
- Patients who have active infections or have severely impaired immune systems.
Precautions
- Blood Monitoring: The regular blood tests are vital for monitoring blood cell count as well as liver functioning.
- Infection Risk: Patients should report any signs of illness (fever or sore throat) promptly.
- Pregnancy: Females with a child-bearing capacity are advised to use contraceptives that work for up to 6 months following the treatment.
- Vaccination: Live vaccines are not recommended when undergoing the treatment.
- Drug Interactions: Discuss with your doctor about any other medication, which includes steroids and anticonvulsants.
Storage
- Keep at room temperature and free of light and moisture.
- Be sure to keep away from young children.
- Avoid using expired medicines.
FAQs – Temoside 20mg (Temozolomide)
How does Temoside work against brain tumors?
The DNA damage is caused by cancerous cells, which prevents the cells from reproducing and leads to the death of cells, which is particularly beneficial for tumor cells that are rapidly growing.
Can I take Temoside with food?
It is advised to consume with a full stomach to ensure greater absorption.
How long is the treatment duration?
The duration of treatment varies based on the type, stage, and response. Most often, it is administered in cycles of five days, every 28 days, over a period of several months.
What should I do if I miss a dose?
Do not miss a dose until promptly if you are close to your next dose. Don’t double-dose.
Can I drink alcohol during treatment?
Avoid drinking alcohol since it could cause more severe effects of liver stress and side effects.
Does Temoside cause hair loss?
Yes, Hair thinning and loss may occur, but it is generally short-term.
Are there special precautions for women who are pregnant?
Yes, Temozolomide may indeed harm the embryo. It is important to avoid pregnancy while taking the course of treatment.
What are signs of serious side effects?
There are signs of fever, bleeding or bruising, intense fatigue, jaundice, or allergies. Consult your physician immediately in the event of any such.
Can Temozolomide be combined with other therapies?
Yes, In fact, it’s often used in conjunction with radiation therapy, as well as other chemotherapy drugs.
Is this medication covered by insurance?
Insurance coverage varies by location and insurance policy. Check with the insurance company.
Summary
Temoside 20mg (Temozolomide) is an important oral chemotherapy drug that is used mostly in the treatment of cancers of the brain cancers, such as glioblastoma multiforme, and anaplastic astrocytoma. Its capability to traverse the blood-brain barrier and to disrupt the DNA of tumors makes it an effective treatment choice.
Though effective, Temozolomide must be under cautious medical monitoring in light of the potential adverse consequences, including bone marrow suppression. Continuous blood testing and adhering of prescribed treatments are crucial.












Reviews
There are no reviews yet.